Quality of life deserves more attention in haematological malignancies – in the design and reporting of trials, in registries and in clinical practice where it needs to be a bigger part of the conversation. The limbic spoke to two clinician-researchers with an interest in raising the profile of quality of life in research and practice. ...
Why QOL needs to feature more in haematological cancer trials
By Mardi Chapman
20 Apr 2021